{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:09:52Z","timestamp":1789171792358,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41380-018-0062-0","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T11:46:26Z","timestamp":1525088786000},"page":"1696-1706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy"],"prefix":"10.1038","volume":"24","author":[{"given":"Antonio","family":"Di Meco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Barrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Merali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer\u2019s Association.","year":"2016","unstructured":"Alzheimer\u2019s Association. 2016 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2016;12:459\u20139.","journal-title":"Alzheimer\u2019s Dement"},{"key":"62_CR2","doi-asserted-by":"crossref","unstructured":"Giannopoulos PG, Pratic\u00f2 D. Alzheimer\u2019s disease. In: Colin RM, Victor, R, editors. Diet and Nutrition in Dementia and Cognitive Decline. London: Elsevier Publisher; 2005. p. 13\u201321.","DOI":"10.1016\/B978-0-12-407824-6.00002-1"},{"issue":"Pt 3","key":"62_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull. 2016;126(Pt 3):238\u201392.","journal-title":"Brain Res Bull"},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609\u201322.","journal-title":"Lancet Neurol"},{"key":"62_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","volume":"36","author":"AD Smith","year":"2016","unstructured":"Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211\u201339.","journal-title":"Annu Rev Nutr"},{"key":"62_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-150140","volume":"46","author":"L Shen","year":"2015","unstructured":"Shen L, Ji HF. Associations between homocysteine, folic Acid, vitamin B12 and Alzheimer\u2019s disease: insights from meta-analyses. J Alzheimers Dis. 2015;46:777\u201390.","journal-title":"J Alzheimers Dis"},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/156720510790691326","volume":"7","author":"JM Zhuo","year":"2010","unstructured":"Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratic\u00f2 D. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res. 2010;7:140\u20139.","journal-title":"Curr Alzheimer Res"},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"1482.e1","DOI":"10.1016\/j.neurobiolaging.2011.12.013","volume":"33","author":"A Fuso","year":"2012","unstructured":"Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, et al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging. 2012;33:1482.e1\u201316.","journal-title":"Neurobiol Aging"},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1096\/fj.10-161828","volume":"24","author":"JM Zhuo","year":"2010","unstructured":"Zhuo JM, Pratic\u00f2 D. Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer\u2019s disease. FASEB J. 2010;24:3895\u2013902.","journal-title":"FASEB J"},{"key":"62_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3233\/JAD-132033","volume":"40","author":"J Suszy\u0144ska-Zajczyk","year":"2014","unstructured":"Suszy\u0144ska-Zajczyk J, Luczak M, Marczak L, Jakubowski H. Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration. J Alzheimers Dis. 2014;40:713\u201326.","journal-title":"J Alzheimers Dis"},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/acel.12550","volume":"16","author":"JG Li","year":"2017","unstructured":"Li JG, Barrero C, Merali S, Pratic\u00f2 D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging Cell. 2017;16:273\u201380.","journal-title":"Aging Cell"},{"key":"62_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","volume":"86","author":"C Andorfer","year":"2003","unstructured":"Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem. 2003;86:582\u201390.","journal-title":"J Neurochem"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/ana.24145","volume":"75","author":"JG Li","year":"2014","unstructured":"Li JG, Chu J, Barrero C, Merali S, Pratic\u00f2 D. Homocysteine exacerbates \u03b2-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles. Ann Neurol. 2014;75:851\u201363.","journal-title":"Ann Neurol"},{"key":"62_CR14","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","volume":"35","author":"A Meco Di","year":"2014","unstructured":"Di Meco A, Lauretti E, Vagnozzi AN, Pratic\u00f2 D. Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer\u2019s disease mice. Neurobiol Aging. 2014;35:2458\u201364.","journal-title":"Neurobiol Aging"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/mp.2013.23","volume":"19","author":"PF Giannopoulos","year":"2014","unstructured":"Giannopoulos PF, Chu J, Sperow M, Li JG, Yu WH, Kirby LG, et al. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer\u2019s disease. Mol Psychiatry. 2014;19:511\u20138.","journal-title":"Mol Psychiatry"},{"key":"62_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0017-2","volume":"7","author":"AN Vagnozzi","year":"2017","unstructured":"Vagnozzi AN, Giannopoulos PF, Pratic\u00f2 D. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy. Transl Psychiatry. 2017;7:1288.","journal-title":"Transl Psychiatry"},{"key":"62_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopsych.2015.01.015","volume":"78","author":"PF Giannopoulos","year":"2015","unstructured":"Giannopoulos PF, Chu J, Sperow M, Li JG, Yu WH, Kirby LG, et al. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy. Biol Psychiatry. 2015;78:693\u2013701.","journal-title":"Biol Psychiatry"},{"key":"62_CR18","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1074\/jbc.M709399200","volume":"283","author":"CA Moncada","year":"2008","unstructured":"Moncada CA, Clarkson A, Perez-Leal O, Merali S. Mechanism and tissue specificity of nicotine-mediated lung S-adenosylmethionine reduction. J Biol Chem. 2008;283:7690\u20136.","journal-title":"J Biol Chem"},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1093\/hmg\/ddu412","volume":"23","author":"YB Joshi","year":"2014","unstructured":"Joshi YB, Giannopoulos PF, Chu J, Sperow M, Kirby LG, Abood ME, et al. Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet. 2014;23:6894\u2013902.","journal-title":"Hum Mol Genet"},{"key":"62_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ana.23642","volume":"72","author":"J Chu","year":"2012","unstructured":"Chu J, Giannopoulos PF, Ceballos-Diaz C, Golde TE, Pratic\u00f2 D. 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease. Ann Neurol. 2012;72:442\u201354.","journal-title":"Ann Neurol"},{"key":"62_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.ajpath.2010.12.032","volume":"178","author":"J Chu","year":"2011","unstructured":"Chu J, Pratic\u00f2 D. Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer\u2019s disease transgenic mouse model involvement of \u03b3-secretase. Am J Pathol. 2011;178:1762\u20139.","journal-title":"Am J Pathol"},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.neurobiolaging.2012.12.009","volume":"34","author":"J Chu","year":"2013","unstructured":"Chu J, Pratic\u00f2 D. 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5. Neurobiol Aging. 2013;34:1549\u201354.","journal-title":"Neurobiol Aging"},{"key":"62_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cphy.c150021","volume":"6","author":"KS McCully","year":"2015","unstructured":"McCully KS. Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol. 2015;6:471\u2013505.","journal-title":"Compr Physiol"},{"key":"62_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-150458","volume":"49","author":"K Miwa","year":"2016","unstructured":"Miwa K, Tanaka M, Okazaki S, Yagita Y, Sakaguchi M, Mochizuki H, et al. Increased total homocysteine levels predict the risk of incident dementia independent of cerebral small-vessel diseases and vascular risk factors. J Alzheimers Dis. 2016;49:503\u201313.","journal-title":"J Alzheimers Dis"},{"key":"62_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","volume":"300","author":"PS Aisen","year":"2008","unstructured":"Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008;300:1774\u201383.","journal-title":"JAMA"},{"key":"62_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jama.2009.211","volume":"301","author":"D Pratico","year":"2009","unstructured":"Pratico D. High-dose B vitamin supplements and Alzheimer disease. JAMA. 2009;301:1020\u20131.","journal-title":"JAMA"},{"key":"62_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","volume":"32","author":"JM Zhuo","year":"2011","unstructured":"Zhuo JM, Wang H, Pratic\u00f2 D. Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci. 2011;32:562\u201371.","journal-title":"Trends Pharmacol Sci"},{"key":"62_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.nbd.2006.01.005","volume":"22","author":"J Pacheco-Quinto","year":"2006","unstructured":"Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, et al. Hyperhomocysteinemic Alzheimer\u2019s mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol Dis. 2006;22:651\u20136.","journal-title":"Neurobiol Dis"},{"key":"62_CR29","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/jth.13340","volume":"14","author":"YC Chung","year":"2016","unstructured":"Chung YC, Kruyer A, Yao Y, Feierman E, Richards A, Strickland S, et al. Hyperhomocysteinemia exacerbates Alzheimer\u2019s disease pathology by way of the \u03b2-amyloid fibrinogen interaction. J Thromb Haemost. 2016;14:1442\u201352.","journal-title":"J Thromb Haemost"},{"key":"62_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-141101","volume":"43","author":"JG Li","year":"2015","unstructured":"Li JG, Pratic\u00f2 D. High levels of homocysteine results in cerebral amyloid angiopathy in mice. J Alzheimers Dis. 2015;43:29\u201335.","journal-title":"J Alzheimers Dis"},{"key":"62_CR31","volume":"6","author":"JG Li","year":"2017","unstructured":"Li JG, Merali S, Pratico D. Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer\u2019s phenotype. Sci Rep. 2017;6:7. 46002","journal-title":"Sci Rep"},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"10741","DOI":"10.1523\/JNEUROSCI.1065-09.2009","volume":"29","author":"M Polydoro","year":"2009","unstructured":"Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci. 2009;29:10741\u20139.","journal-title":"J Neurosci"},{"key":"62_CR33","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/hmg\/ddx088","volume":"26","author":"JG Li","year":"2017","unstructured":"Li JG, Barrero C, Merali S, Pratic\u00f2 D. Genetic absence of ALOX5 protects from homocysteine-induced memory impairment, tau phosphorylation and synaptic pathology. Hum Mol Genet. 2017;26:1855\u201362.","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0062-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:57:59Z","timestamp":1684616279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0062-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0062-0","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}